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1. Introduction 
Since the original use of the nucleoside analogue 
.5,6dichloro-1+3-D-ribofuranosylbenzimidazole (DRB) 
in studies on suppression of influenza virus multipli- 
cation [ 11, considerable information dealing with the 
effects of DRB has been accumulated (reviewed [2,3]). 
A selective influence of DRB on formation of hetero- 
geneous nuclear RNA (hnRNA) in various cell systems 
has been documented [4,5], and more detailed studies 
furnished evidence in support of interference with 
some early events in transcription of hnRNA-producing 
genes [6]. Experiments with Chironomus tentans 
salivary gland cells [7,8] and HeLa cells [9] led to the 
conclusion that DRB inhibits chain initiation, whereas 
an examination of the effects of DRB on adenovirus 
transcription in HeLa cells pointed to an inhibition 
site 400-800 nucleotides downstream from the 
promotor site [lo]. 
Clarification of the mechanism whereby DRB 
affects hnRNA synthesis obviously requires informa- 
tion about the intracellular fate of this analogue. 
Ideally, the effect of DRB should be examined in a 
cell-free RNA synthesizing system which includes 
RNA polymerase II. However, attempts to carry out 
the ‘right experiment’ have been hampered by lack 
of information as to the active inhibitory form of 
DRB. 
DRB, as a purine nucleoside analogue, may be 
metabolized (e.g., phosphorylated), so that the inhibi- 
tory form consists of a DRB derivative, and not the 
nucleoside itself. A logical approach to this problem 
is to treat cells with radioactive DRB (labeled in the 
benzimidazole moiety) and to identify possible labeled 
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DRB metabolites and the associated metabolic 
processes involved. In one such attempt to examine 
the intracellular fate of DRB [ Ill, difficulties associated 
with exchange labeling of DRB were circumvented 
by incubating Ehrlich ascites cells in the presence of 
unlabeled DRB and [32P]phosphate and subsequently 
analyzing the acid-soluble nucleotides by twodimen- 
sional chromatography. With DRB monophosphate and 
triphosphate as reference substances, it was concluded 
that DRB is not phosphorylated in vivo. 
We now describe the results of experiments which 
demonstrate that [3H]DRB administered to salivary 
gland cells of Chironomus tentans istransported across 
the cell membrane and is, to an appreciable extent, 
metabolized to the phosphate. Furthermore, only the 
monophosphate of DRB, but no di- or tri-phosphates, 
are detectable in the ethanol-soluble cell extract, and 
no measurable fraction of [ 3H] DRB is incorporated 
into any nucleic acid fraction. 
2. Materials and methods 
[‘H]Uridine (50 Ci/mmol) was a product of the 
Radiochemical Centre (Amersham). TLC aluminium 
sheets (precoated with aluminium oxide 150 F254 
neutral, type T) were obtained from Merck (Darmstadt) 
and Polygram Cel300 UV2% cellulose sheets from 
Machery-Nagel (Buren, FRG). Alkaline phosphatase 
(calf intestine, grade I, EC 3.1.3.1) and snake venom 
phosphodiesterase (PDE, EC 3.1.4.1) were products 
of Boehringer (Mannheim). The various normal 
nucleotides used as mobility markers were products 
of Sigma Chem. Co. (St. Louis, MO). 
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DRB-5’.monophosphate was prepared by phos- 
phorylation of DRB by the procedure in [ 121. Since 
this method occasionally gives a mixture including 
the 2’(3’)-phosphates [ 131, the product of phos- 
phorylation was purified on a Dowex (HCOO-) 
column, and the purified 5’.phosphate of DRB 
obtained as the free acid in crystalline form. It was 
hydrolyzed quantitatively to DRB by alkaline phos- 
phatase or 5’.nucleotidase. 
[3H]DRB, labelled by exchange with tritiated 
water without catalyst, was obtained from the Radio- 
chemical Center (Amersham). The crude preparation 
was subjected to purification by preparative TLC. Its 
chemical purity was high, as judged by its ultraviolet 
absorption spectrum, but its radiochemical purity was 
poor. The product was fractionated on aluminium 
oxide layers with n-butanol/HzO (6: l), the [‘H]DRB 
band (RF = 0.6) localized under a dark ultraviolet 
lamp and eluted overnight with 1 ml 70% ethanol at 
4°C. The eluate was concentrated and rechromato- 
graphed, and the [3H]DRB stored in 70% ethanol at 
4°C. The purified radioactive product was tested for 
purity in 3 different separation systems ( ee section 3). 
Its specific activity was about 1 Ci/mmol. 
2 .I .I Biological material and labeling conditions 
Salivary glands were isolated from fourth instar 
larvae of Chironomus tentans, and the explanted 
glandsincubatedwith t3H]DRB in modified Cannon’s 
medium at 18°C as in [ 61. 
2 2. Extraction of cells 
Following incubation the cells were rapidly rinsed 
in -1 ml fresh medium and then extracted 3 times 
(for 20 min each) with 100 yl volumes of 70% 
ethanol. About 90% of the radioactivity was taken up 
in the first extract. Extraction with aqueous ethanol 
was employed in place of the usual cold HC104 to 
avoid the presence of salts in the extracts following 
neutralization of the acid. The extraction efficiency 
by both methods is similar. 
2.3. Separation techniques and measurement of radio- 
activity 
Three separation methods were employed to 
fractionate nucleotides: 
(1) TLC on aluminium oxide coated aluminium 
sheets,withn-butanol/HzO (6: 1) for development; 
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(2) Thin-layer electrophoresis on Polygram Cel300 
plastic sheets, using 0.05 M citrate buffer (pH 5.2) 
at 20 V/cm for -1.5 h in a Desaga (Heidelberg) 
thin-layer electrophoresis apparatus. 
(3) Electrophoresis in 1% agarose gel performed as in 
[61- 
At the end of the run, the sheets were cut and the 
strrps transferred to Packard scintillation vials. To 
each vial 25 ~1 water was added, followed by 10 ml 
scintillator fluid (toluene and Permablend III, from 
Packard), and the vials cooled to 4°C before counting 
in a Packard (3380) liquid scintillation spectrometer. 
The counting efficiency was -35% at a background 
level of -10 cpm. 
3. Results and discussion 
3 .I. Radiochemical purity and biological activity of 
tn’tium labelled DRB 
Following purification (see above), the product was 
tested for purity by 3 different separation techniques. 
Figure 1 exhibits the distribution of purified labeled 
DRB after thin-layer chromatography on aluminium 
sheets (fig.1 a) and after thin-layer electrophoresis on 
Polygram plastic sheets (fig.lb). Both the chromato- 
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Fig.1. Thin-layer chromatography (a) and thin-layer electro- 
phoresis (b) of [ ‘H]DRB after purification. 
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graphic and electrophoretic patterns contain one peak 
comigrating with added unlabeled DRB. Electro- 
phoresis in 1% agarose gel at pH 8 led to similar 
results (not shown). The radiochemical purity of 
[3H]DRB (the peak material compared with the total 
radioactivity) was estimated to be > 95%. 
Possible structural changes arising during exchange 
labeling of DRB, and perhaps undetectable by the 
foregoing separation criteria, might affect the biological 
activity of the compound. To check this, salivary 
glands were incubated with [3H]DRB for 60 min, and 
the distribution of labeled RNA, using [‘Hluridine 
as an RNA precursor, analyzed by gel electrophoresis. 
The results reflected the normal expected ifferential 
inhibition of hnRNAlabelling [4], so that the exchange 
labeling of DRB did not affect its biological activity. 
3.2.Phosphorylation of(3H]DRB to monophos- 
phate, but not to the diphosphate and/or tri- 
phosphate 
Explanted salivary glands were incubated with 
65 pM of [3H]DRB for 180 mm and a portion of the 
nucleotide xtract was subjected to thin-layer electro- 
phoresis along with appropriate reference markers, 
viz. DRB-5’.monophosphate, 5’~Ah@‘, ADP, ATP, 
UTP. The results, depicted in iig.2, demonstrate he 
presence of two main radiolabeled peaks. One migrates 
slowly, like nucleosides in general, towards the 
cathode, and overlapping the DRB marker. The 
faster-moving fraction migrates towards the anode, 
and closely mimics the electrophoretic mobility of 
the reference DRBd’-monophosphate, although the 
two peaks do not perfectly coincide. It is also clear 
from fig.2 that there is no significant peak of labeled 
material which might be ascribed to higher phos- 
phorylated erivatives, uch as the diphosphate or tri- 
phosphate. The purine nucleoside analogue DRB 
consequently appears to be metabolized to mono- 
phosphate(s) in the salivary gland cells, but, in con- 
trast to other known adenosine analogues [ 141, and 
normal nucleosides, the DRB-monophosphate is not 
further phosphorylated in our cellular system. 
Identification of the labeled monophosphate-like 
fraction in DRB-treated cells was further supported 
by experiments in which, following treatment of the 
cells with [3H]DRB, the ethanol extract was sub- 
jected to the action of alkaline phosphatase and snake 
venom phosphodiesterase, and the resulting product(s) 
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Fig.2. Electrophoretic analysis of labeled ethanol-soluble cell 
extract. Salivary glands from 10 Larvae incubated with [ 'H ] - 
DRB for 180 mm at 18’C. The cells were then extracted with 
70% ethanol and the extract subjected to thin-layer electro- 
phoresis on precoated plastic sheets. DRB, DRB monophos- 
phate, AMP, ADP, ATP and UTP were used as reference sub- 
stances. For other data see section 2. 
analyzed in 1% agarose gel. The agarose gel system is 
preferable to thin-layer systems for analysis of the 
products of enzyme digestion, because the use of gel 
as supporting medium obviates the need for evapora- 
tion of samples to dryness before analysis. The gel 
electrophoretic pattern of labeled DRB extract in 
fig.3 displays the expected two main peaks, along 
with some additional labeled material distributed as a 
weaker broad peak between the two major peaks. 
Treatment of a portion of the same xtract with 
alkaline phosphatase completely liquidates the DRB- 
monophosphate like peak. Simultaneously, the amount 
of label in the nucleoside (DRB) peak increases 
almost quantitatively by the amount present in the 
monophosphate p ak. Hence dephosphorylation 
releases DRB from the monophosphate fraction. The 
labeled material located between the two main peaks 
is also partially susceptible to alkaline phosphatase, 
but its nature remains unknown and requires further 
study. 
When a portion of the cell extract was treated with 
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Fig.3. Electrophoretic analyses of labeled ethanol-soluble cell 
extract with and without treatment with alkaline phosphatase. 
Salivary glands from 10 animals were incubated with [ 3H]DRB 
for 180 min at 18’C. After ethanol extraction, -10% of the 
extract was evaporated to dryness. Next, the material was 
dissolved in 20 ~1 of a solution containing 0.1 M glycine buffer 
(pH lO.S), 1 mM MgCl,, 0.1 mM ZnCl,, 2 pg each of DRB, 
DRB monophosphate and ATP and 0.02 U alkaline phos- 
phatase, and the sample solution was kept at 37°C for 15 min. 
After cooling, the sample was subjected to electrophoresis in 
1% agarose. Another 10% of the ethanol extract was treated 
without enzyme in an otherwise similar procedure: (-o-) 
alkaline phosphatase; (a-) control. 
phosphodiesterase in 0.2 M Tris-HCl buffer (pH 9.2) 
for 15 min at 37°C with ATP as an internal reference, 
no significant hydrolysis of the labeled DRB phosphate 
fraction could be detected (result not shown). Hence, 
on the basis of comigration with the DRB-monophos- 
phate marker, sensitivity to alkaline phosphatase, and 
resistance to snake venom phosphodiesterase, the
product of intracellular metabolism of DRB is iden- 
tified as a monophosphate. 
Our results differ from those in [ 113, where no 
measurable intracellular phosphorylation of DRB was 
found. However, their procedure differed from ours in 
two important respects: 
(i) The use of a different cellular system, Ehrlich 
ascites cells; 
(ii) Incubation in this system of cold DRB with 
[32P]phosphate, and looking for 32P-labeled DRB. 
Nonetheless, it is difficult to reconcile these conflict- 
ing results, the more so in view of the relatively good 
conformity in the mode of inhibitory action of DRB 
in insect cells and in mammalian cell systems like 
HeLa and L cells. It will obviously be necessary to 
establish whether DRB exerts a selective and reversible 
inhibitory effect on hnRNA formation in intact 
Ehrlich ascites cells, in a manner esembling that 
established in other cell types, with a site of action at 
or close to the initiation site, before one can meaning- 
fully evaluate the significance of the lack of phos- 
phorylation of DRB in such cells [ 111 as compared 
to the phosphorylation observed in the present study. 
3.3. DRB is not incorporated into nucleic acids 
Since various nucleoside analogues may be incor- 
porated into nucleic acids following their intracellular 
phosphorylation [ 141, and thereby interrupt RNA 
synthesis, it becomes of interest o establish whether 
this occurs with DRB. Salivary glands were labeled for 
180 min in the presence of 65 PM [3H]DRB, followed 
by analysis of the ethanol-insoluble radioactivity. 
Less than 5% of the total label was insoluble and 
remained bound to the cell structure. Solubilization 
of the cells in sodium dodecyl sulphate solution, 
followed by electrophoresis in agarose gel [6] did not 
reveal any appreciable incorporation of [3H]DRB in 
any particular nucleic acid fraction (result not shown). 
This failure of salivary gland cells to incorporate DRB 
into nucleic acids is consistent with the absence of 
formation of di- and triphosphates of DRB. Hence 
the transcription block by DRB does not appear to 
depend on competitive processes between DRB tri- 
phosphates and endogenous nucleoside triphosphates, 
in agreement with in vitro results [111. 
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